𝔖 Bobbio Scriptorium
✦   LIBER   ✦

CA 19-9 and Survival in Advanced and Unresectable Pancreatic Adenocarcinoma and Cholangiocarcinoma

✍ Scribed by Clinton W. Ali; Thomas F. Kaye; Douglas J. A. Adamson; Iain S. Tait; Francesco M. Polignano; Martin S. Highley

Book ID
107573651
Publisher
Springer US
Year
2007
Tongue
English
Weight
228 KB
Volume
38
Category
Article
ISSN
1941-6628

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

CA 19-9 and pancreatic adenocarcinoma
CA 19-9 and pancreatic adenocarcinoma
✍ Farouk Safi; Hans G. Beger; Reinhard Bittner; Markus BΓΌchler; Wolfgang Krautzber πŸ“‚ Article πŸ“… 1986 πŸ› John Wiley and Sons 🌐 English βš– 327 KB

The diagnostic place value of CA 19-9, a tumor-associated antigen, was tested in 611 patients. This group of patients included 273 patients who suffered from a malignant disease (48 patients with pancreatic carcinomas and 225 patients with extrapancreatic malignant growths) and 338 patients with ben

CA 19-9 and CA 50 in Benign and malignan
CA 19-9 and CA 50 in Benign and malignant pancreatic and biliary diseases
✍ Michela Paganuzzi; Marina Onetto; Paola Marroni; Daniela Barone; Massimo Conio; πŸ“‚ Article πŸ“… 1988 πŸ› John Wiley and Sons 🌐 English βš– 555 KB

Serum concentrations of the CA 19-9 and CA 50 antigens were determined in 129 patients with malignant and benign biliary and pancreatic diseases. Values for the two markers were highly correlated (P < 0.001). The concentrations of CA 19-9 and CA 50 were positive in 84.6% and 80.7% of patients with p